Yahoo Web Search

Search results

1. Ionis Pharmaceuticals - Local Result

   • 

   • A
     Isis Pharmaceuticals

     Pharmaceutical Wholesaler, Government & Community

     2855 Gazelle Ct, Carlsbad, CA · (760) 931-9200
     
     Website
   Add or update your business

2. www.ionispharma.comEvery Moment Matters | Ionis - Ionis Pharmaceuticals

   www.ionispharma.com

   • Cached

   Ionis is a leader in RNA-targeted therapeutics for rare and common diseases. Learn about its history, pipeline, partnerships, and career opportunities.

   • Careers

     Ionis is where passionate, driven people come together to...

     Intern Program

     · Post Doctoral

   • Antisense Pipeline

     Ionis Innovation. The Ionis antisense pipeline. Our...

     Grants & Sponsorships

     · Patient Experiences

     · Patient Resources

     · Media Center

   • Press Releases

     Ionis poised for continued momentum in 2024 with product...

   • Working at Ionis

     It is the policy of Ionis Pharmaceuticals, Inc. to provide...

   • About

     Building Something Greater Than Ourselves. Ionis is building...

   • Ionis Innovation

     Ionis’ antisense technology. With RNA as the target that...

   • Patients

     Ionis community collaborations. At Ionis, the issues that...

   • Medicines

     A perpetual and efficient innovation machine. Our platform...

3. Top Stories

   • YAHOO!Finance

     Ionis to hold donidalorsen Phase 3 data webcast

     Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Friday, May 31th at 8:00 a.m. Eastern Time to discuss the donidalorsen Phase 3 OASIS-HAE and OASISplus (Open-Label Extension and Switch cohorts) study results that will be presented in three late-breaking oral presentations at the 2024 European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Valencia,

     9 hours ago

   • bovnews

     Ionis Pharmaceuticals Inc (IONS) Stock is the one stock you should own forever

     Wolfe Research raised the price target for the Ionis Pharmaceuticals Inc (NASDAQ:IONS) stock from “a Peer perform” to “an Outperform”. The rating was released on April 10, 2024, according to finviz. We previously noted in another research note published on January 02,

     6 days ago

   • 

     Business Insider

     Ionis, Biogen Down on Ending Development of ALS Drug

     2 weeks ago

   • Benzinga on MSN.com

     Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another

     2 weeks ago

   • Business Insider

     Ionis Reports Positive Topline Data From The HALOS Phase 1/2a Study In Angelman Syndrome

     (RTTNews) - Ionis Pharmaceuticals, Inc. (IONS) Thursday reported positive topline data from the HALOS Phase 1/2a study of ION582 in Angelman syndrome, a neurodevelopmental disorder. ION582 was safe and well tolerated in the study and showed consistent ...

     2 weeks ago

   View all

4. en.wikipedia.org › wiki › Ionis_PharmaceuticalsIonis Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Ionis_Pharmaceuticals

   • Cached

   Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.

5. ir.ionispharma.com › news-releases › news-releaseIonis announces positive topline results from Phase 1/2a ...

   ir.ionispharma.com › news-releases › news-release

   • Cached

   May 16, 2024 · CARLSBAD, Calif., May 16, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline data from the HALOS Phase 1/2a open-label study of ION582 in Angelman syndrome.

6. Videos

   • 

     0:55

     youtube.com

     A Culture of YES | Ionis Pharmaceuticals

     May 6, 2019

     269 Views

   • 

     5:42

     youtube.com

     The Early Years: 1994-1999 | Ionis Pharmaceuticals

     Dec 10, 2019

     97 Views

   • 

     6:58

     youtube.com

     The Beginning: 1989-1994 | Ionis Pharmaceuticals

     Dec 10, 2019

     155 Views

   View all

7. www.google.com › finance › quoteIonis Pharmaceuticals Inc (IONS) Stock Price & News - Google

   www.google.com › finance › quote

   • Cached

   Get the latest Ionis Pharmaceuticals Inc (IONS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

8. People also ask

   Who is Ionis Pharmaceuticals?

   • Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA -targeted therapeutics.

   Ionis Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ionis_Pharmaceuticals

   See all results for this question

   How much does Ionis pay for mipomersen?

   • In May 2016, Ionis licensed the rights to the drug to Kastle Therapeutics for $15 million upfront with another $10 million due in May 2019, up to $70 million in milestones based on sales, and royalties, with Ionis paying 3% royalty and 3% of non-cash royalty it receives to Genzyme. Mipomersen has still not been approved in Europe.

   Ionis Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ionis_Pharmaceuticals

   See all results for this question

   Who owns Isis Pharmaceuticals?

   • The company was named Isis Pharmaceuticals until December 2015. The company was founded in 1989 as Isis Pharmaceuticals by Stanley T. Crooke, a former head of research of GlaxoSmithKline, with a goal to commercialize antisense therapy.

   Ionis Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ionis_Pharmaceuticals

   See all results for this question

   Why should you choose Ionis?

   • We look to patients to better understand what it means to live with a disease, so our genetic medicines can make the most meaningful contribution to improve their lives. As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients.

   Every Moment Matters | Ionis - Ionis Pharmaceuticals

   www.ionispharma.com/

   See all results for this question